A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients

被引:0
|
作者
Kemp, EH [1 ]
Ajjan, RA
Husebye, ES
Peterson, P
Uibo, R
Imrie, H
Pearce, SHS
Watson, PF
Weetman, AP
机构
[1] Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Div Clin Sci,Sect Med, Sheffield S5 7AU, S Yorkshire, England
[2] Univ Bergen, Haukeland Hosp, Dept Med B, N-5021 Bergen, Norway
[3] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland
[4] Tartu State Univ, Inst Gen & Mol Pathol, EE-202400 Tartu, Estonia
[5] Univ Newcastle Upon Tyne, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Recent studies have demonstrated an association between a microsatellite polymorphism of the CTLA-4 gene, specifically a 106 base pair allele, and both Graves' disease and autoimmune hypothyroidism, The aim of the present study was to determine whether the same polymorphism of the CTLA-4 gene was associated with autoimmune Addison's disease. DESIGN AND PATIENTS We analysed a microsatellite polymorphism (variant lengths of a dinucleotide (AT), repeat) within exon 3 of the CTLA-4 gene in the following groups: 21 English patients with non-associated Addison's disease, 18 with autoimmune polyglandular syndrome type 2 (APS2) and 173 healthy control subjects; 26 Norwegian patients with nonassociated Addison's disease, 9 with autoimmune polyglandular syndrome type 1 (APS1), 17 with APS2 and 100 controls; 3 Finnish patients with non-associated Addison's disease, 5 with APS2 and 71 controls; 10 Estonian patients with non-associated Addison's disease, 2 with APS2 and 45 controls. MEASUREMENTS The CTLA-4 microsatellite gene polymorphisms were determined by polymerase chain reaction amplification of genomic DNA and resolution of the products on sequencing gels. RESULTS The frequency of the 106 base pair allele was significantly increased in the groups of English patients with either non-associated Addison's disease or APS2 (P = 0.02 and 0.04, respectively), when compared to healthy controls with no clinical evidence or family history of either Addison's disease or any other autoimmune disorder. For Norwegian patients with either non-associated Addison's disease, APS1 or APS2, there was no association (P = 0.69, 0.62 and 0.97, respectively). This was also the case for Finnish patients with either non-associated Addison's disease or APS2 (P = 0.23 and 0.28, respectively) and for Estonian patients with either non-associated Addison's disease or APS2 (P = 0.34 and 0.29, respectively). CONCLUSIONS These results indicate that differences exist in the frequency of the 106 base pair allele in different population groups and in only the English population was the 106 base pair allele associated with Addison's disease.
引用
收藏
页码:609 / 613
页数:5
相关论文
共 50 条
  • [21] Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease
    Duzgun, N.
    Duman, T.
    Haydardedeoglu, F. E.
    Tutkak, H.
    TISSUE ANTIGENS, 2009, 74 (06): : 539 - 542
  • [22] Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism at position+49 in exon 1 and susceptibility to cervical cancer
    Frydecka, Irena
    Pawlak, Edyta
    Wlodarska-Polinska, Irena
    Tutak, Anna
    Karabon, Lidia
    Suwalska, Katarzyna
    Kornafel, Jan
    ANNALS OF ONCOLOGY, 2006, 17 : 242 - 242
  • [23] Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation
    Dwivedi, Mitesh
    Laddha, Naresh C.
    Imran, Mohomad
    Shah, Bela J.
    Begum, Rasheedunnisa
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 737 - 740
  • [24] A DNA vaccine against cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) prevents tumor growth
    Lan, Keng-Hsueh
    Liu, Yu-Chang
    Shih, Yi-Sheng
    Tsaid, Chang-Liang
    Yen, Sang-Hue
    Lan, Keng-Li
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (02) : 222 - 228
  • [25] Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy
    Kim, Gil-Ran
    Choi, Je-Min
    MOLECULES AND CELLS, 2022, 45 (08) : 513 - 521
  • [26] CYTOTOXIC T-LYMPHOCYTE ANTIGEN-4 (CTLA-4) EXPRESSED IN HUMAN MESENCHYMAL STROMAL CELLS
    Schoenbeck, K.
    Tran, C. L.
    Strehl, C.
    Gaber, T.
    Jakstadt, M.
    Roehner, E.
    Burmester, G. R.
    Buttgereit, F.
    Hoff, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 794 - 794
  • [27] Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer
    Thompson, R. Houston
    Allison, James P.
    Kwon, Eugene D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 442 - 447
  • [28] Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population
    Genc, S
    Genc, K
    Sercan, O
    Kizildag, S
    Gulay, Z
    Atay, T
    Dundar, B
    Sakizli, M
    Büyükgebiz, A
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2004, 17 (05): : 731 - 735
  • [29] Cytotoxic T-lymphocyte antigen-4 (CTLA-4) polymorphisms and susceptibility to non Hodgkin's lymphoma.
    Monne, M
    Piras, G
    Palmas, AD
    Murineddu, M
    Arru, L
    Latte, G
    Uras, A
    Gabbas, A
    BLOOD, 2002, 100 (11) : 567A - 567A
  • [30] Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations
    Bednarczuk, T
    Hiromatsu, Y
    Fukutani, T
    Jazdzewski, K
    Miskiewicz, P
    Osikowska, M
    Nauman, J
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (01) : 13 - 18